Lisbon, Portugal
February 13 - February 14, 2009
There are a wide range of ART procedures, from ovary stimulation to embryo transplantation, and after thirty years of IVF many advances and results have been reached. Today the available pharmacological treatments and procedures can offer several options thus allowing a personalized management of infertility.
The aim of this conference is to address selection criteria for patients that can benefit from tailored protocols and to review present as well as future tools aimed at optimise outcomes. This event will also allow the possibility for participants and speakers to exchange experiences as well as build future strategies for tailored treatments.
LEARNING OBJECTIVES
At the end of this conference, participants will be able to:
- Apply the latest updates on male and female genetic factors influencing gonadal function and physiological mechanisms involving gonadotrophins;
- Optimize the use of gonadotrophins in ovarian stimulation on a patient tailored basis and analyze the putative markers of ovarian response;
- Learn more about laboratory procedures aimed at improving ART outcomes;
- Discuss with couples the management of health and life style factors that influence fertility and infertility treatment outcomes.
TARGET AUDIENCE
This programme is targeted to clinicians and scientists working on Assisted Reproduction Techniques
Serono Symposia International Foundation (www.seronosymposia.org) will submit this program New Frontiers in Fertility (February 13-14, 2009 - Lisbon, Portugal) for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME), the Royal College of Physicians, UK and the Italian Ministry of Health.
